Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review.
Ghabrash MF, Bahremand A, Veilleux M, Blais-Normandin G, Chicoine G, Sutra-Cole C, Kaur N, Ziegler D, Dubreucq S, Juteau LC, Lestage L, Jutras-Aswad D. Ghabrash MF, et al. Among authors: juteau lc. J Dual Diagn. 2020 Apr-Jun;16(2):191-207. doi: 10.1080/15504263.2020.1726549. Epub 2020 Feb 23. J Dual Diagn. 2020. PMID: 32089124 Review.
Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial.
Rizkallah E, Mongeau-Pérusse V, Lamanuzzi L, Castenada-Ouellet S, Stip E, Juteau LC, Brissette S, Bruneau J, Dubreucq S, Jutras-Aswad D. Rizkallah E, et al. Among authors: juteau lc. Pharmacol Biochem Behav. 2022 May;216:173376. doi: 10.1016/j.pbb.2022.173376. Epub 2022 Mar 31. Pharmacol Biochem Behav. 2022. PMID: 35367279 Free article. Clinical Trial.
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study.
Elkrief L, Bastien G, McAnulty C, Bakouni H, Hébert FO, Socias ME, Le Foll B, Lim R, Ledjiar O, Marsan S, Brissette S, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Elkrief L, et al. J Subst Use Addict Treat. 2023 Jun;149:209031. doi: 10.1016/j.josat.2023.209031. Epub 2023 Mar 30. J Subst Use Addict Treat. 2023. PMID: 37003540 Free article. Clinical Trial.